Skip to main content

Table 1 The accuracy, precision and recovery for the assay of efavirenz

From: A simple high-performance liquid chromatographic assay for concurrent quantification of lumefantrine and efavirenz in human plasma from malaria–HIV co-infected individuals

Theoretical concentration

Intra-day

Inter-day

Assay (mean ± SD)

Accuracy (%)

Precision (%)

Assay (mean ± SD)

Accuracy (%)

Precision (%)

Accuracy and precision for Efavirenz

Low (500 ng/mL)

585.85 ± 76.89

117.17

13.12

578.85 ± 7.35

115.77

1.27

Medium (4500 ng/mL)

4685.12 ± 72.21

104.11

1.54

4776.50 ± 83.07

106.14

1.74

High (18,000 ng/mL)

20,024.70 ± 150.21

111.25

0.75

19,993.93 ± 85.30

111.08

0.43

Accuracy and precision for lumefantrine

Low (400 ng/mL)

412.36 ± 20.53

103.09

4.91

420.55 ± 10.01

105.14

2.38

Medium (2000 ng/mL)

1907.28 ± 122.95

95.36

6.45

1913.30 ± 22.00

95.36

1.15

High (15,000 ng/mL)

15,171.61 ± 678.18

101.14

4.47

14,702.94 ± 427.15

98.02

2.91

Recoveries for efavirenz and lumefantrine

Efavirenz

Lumefantrine

Theoretical concentration

Recovery (%)

Theoretical concentration

Recovery (%)

Low (500 ng/mL)

117.13 ± 2.28

Low (400 ng/mL)

75.27 ± 1.82

Medium (4500 ng/mL)

109.08 ± 2.38

Medium (2000 ng/mL)

72.64 ± 0.84

High (18,000 ng/mL)

111.72 ± 3.09

High (15,000 ng/mL)

76.62 ± 2.16